Hemoptysis Presentation
Patient coughing up blood
All Pathways
Pulmonary MedicineEmergency
Massive Hemoptysis Management
Massive Hemoptysis Management: Hemoptysis Presentation → Massive Hemoptysis? → Non-Massive Hemoptysis → Treat Underlying Cause.
Pathway Overview
15 steps
Algorithm Steps
15 total
01Start 02Decision Massive Hemoptysis?
Quantify and assess severity
- Massive: >100-200mL/24h OR
- Hemodynamic instability
- Respiratory compromise
- Risk of asphyxiation
- Life-threatening: >500mL/24h
03Action Non-Massive Hemoptysis
Outpatient workup if stable
- CXR as initial imaging
- CT chest if CXR abnormal
- Bronchoscopy if recurrent
- Treat underlying cause
- Follow-up arranged
04Outcome Treat Underlying Cause
Address etiology
- Bronchiectasis: Optimize treatment
- TB: Anti-TB therapy
- Malignancy: Oncology referral
- Aspergilloma: Consider resection
- Pulmonary HTN: Specific therapy
05Warning ⚠️ Immediate Stabilization
Protect airway, ensure oxygenation
- Large bore IV access x2
- Type and crossmatch
- High-flow oxygen
- Position bleeding side down (if known)
- Reverse anticoagulation if applicable
06Decision Airway Secure?
Can patient protect airway?
- Alert and protecting airway
- Maintaining oxygenation
- Not drowning in blood
07Action Intubation Required
Secure definitive airway
- Large ETT (≥8.0) for bronchoscopy access
- Consider mainstem intubation to non-bleeding lung
- Consider double-lumen tube if skilled
- Bronchial blocker alternative
- Video laryngoscopy preferred
08Action Localize Bleeding Source
Imaging and bronchoscopy
- CTA chest: Identify source and etiology
- Bronchoscopy: Direct visualization, therapeutic
- 90% of massive hemoptysis from bronchial arteries
- 10% from pulmonary arteries
09Action Bronchoscopic Interventions
Temporizing measures
- Cold saline lavage
- Topical vasoconstrictors (epinephrine 1:20,000)
- Endobronchial tamponade (balloon, Fogarty catheter)
- Oxidized cellulose or fibrin glue
- Electrocautery/laser if available
10Action Bronchial Artery Embolization (BAE)
First-line definitive treatment
- Success rate 70-90% immediate control
- Recurrence 10-30% at 1 year
- Identify ALL abnormal bronchial arteries
- Avoid spinal artery embolization (paralysis risk)
- May need repeat procedures
11Decision BAE Successful?
Bleeding controlled?
12Action Post-Procedure Management
ICU monitoring
- ICU admission for monitoring
- Treat underlying condition
- Antibiotics if infection
- Antifungal if aspergilloma
- Plan for recurrence
- Path rejoins step 04Shared downstream outcome
13Action Surgical Intervention
When embolization fails or not possible
- Lobectomy or pneumonectomy
- High mortality in emergency (20-40%)
- Better outcomes in elective/semi-elective
- Consider if: Localized disease, good pulmonary reserve
- Avoid if: Bilateral disease, poor lung function
- Path rejoins step 12Shared downstream outcome
14Decision CTA Findings?
Identify vascular source
- Bronchial artery hypertrophy
- Pulmonary artery pseudoaneurysm
- Aortobronchial fistula
- No clear source
- Path rejoins step 10Shared downstream outcome
15Action Pulmonary Artery Source
Different approach needed
- PA pseudoaneurysm (Rasmussen)
- PAA embolization
- May need coils, plugs
- Higher complexity procedure
- Path rejoins step 11Shared downstream outcome
- Path rejoins step 08Shared downstream outcome
Guideline Source
A systematic approach to the management of massive hemoptysis
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Definition of massive hemoptysis varies (100-1000mL/24h)
- Bronchial artery embolization availability varies
- Requires multidisciplinary approach
- Does not cover anticoagulation reversal in detail
Applicable Regions
Global
Global: Interventional radiology and thoracic surgery availability varies
Version 1Next review: 2027-01-01
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Pulmonary Embolism Severity Index (PESI)
30-day mortality risk stratification for acute pulmonary embolism
Open page
Compare
AttendMe.ai vs DynaMed
See how this pathway workflow compares against DynaMed.
Open page
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Start free
Related Resources
Frequently Asked Questions
What is the Massive Hemoptysis Management?
The Massive Hemoptysis Management is a emergency clinical algorithm for Pulmonary Medicine. It provides a structured decision tree to guide clinical decision-making, based on A systematic approach to the management of massive hemoptysis.
What guideline is the Massive Hemoptysis Management based on?
This algorithm is based on A systematic approach to the management of massive hemoptysis (DOI: 10.21037/jtd.2017.06.41).
What are the limitations of the Massive Hemoptysis Management?
Known limitations include: Definition of massive hemoptysis varies (100-1000mL/24h); Bronchial artery embolization availability varies; Requires multidisciplinary approach; Does not cover anticoagulation reversal in detail. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Massive Hemoptysis Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free